Objective: To assess the accuracy of measurements of end tidal carbon dioxide (CO 2 ) during neonatal transport compared with arterial and transcutaneous measurements. Design: Paired end tidal and transcutaneous CO 2 recordings were taken frequently during road transport of 21 ventilated neonates. The first paired CO 2 values were compared with an arterial blood gas. The differences between arterial CO 2 (PaCO 2 ), transcutaneous CO 2 (TcPCO 2 ), and end tidal CO 2 (PetCO 2 ) were analysed. The Bland-Altman method was used to assess bias and repeatability. Results: PetCO 2 correlated strongly with PaCO 2 and TcPCO 2 . However, PetCO 2 underestimated PaCO 2 at a clinically unacceptable level (mean (SD) 1.1 (0.70) kPa) and did not trend reliably over time within individual subjects. The PetCO 2 bias was independent of PaCO 2 and severity of lung disease. Conclusions: PetCO 2 had an unacceptable under-recording bias. TcPCO 2 should currently be considered the preferred method of non-invasive CO 2 monitoring for neonatal transport.
C ontinuous non-invasive carbon dioxide (CO 2 ) monitoring has become an important bedside tool in neonatal intensive care. Transported sick neonates should receive full intensive care, but arterial blood gas monitoring is not possible. Assessing the efficacy of ventilation during neonatal transport is challenging. Continuous non-invasive CO 2 monitoring has been shown to increase the likelihood of the patient arriving at the receiving hospital with a normal pH and partial pressure of CO 2 (PaCO 2 ). 1 Transcutaneous CO 2 monitoring is the most commonly used non-invasive CO 2 monitoring system in neonatal intensive care and has been shown to accurately predict PaCO 2 and monitor CO 2 trends. 1 2 Calibrated transcutaneous partial pressure of carbon dioxide (TcPCO 2 ) has been shown to reliably approximate PaCO 2 during neonatal transport and has been recommended as an alternative to frequent PaCO 2 measurements. 1 However, TcPCO 2 devices are difficult to use, 3 4 bulky, and weigh between 2 and 6 kg, thus limiting their use during neonatal transport.
End tidal CO 2 (PetCO 2 ) monitors are lightweight and may indirectly monitor PaCO 2 . [5] [6] [7] [8] Hence, PetCO 2 may be more useful during transportation than TcPCO 2 monitoring. Studies of PetCO 2 monitoring in newborn infants have had mixed results, primarily because of the effects of ventilation perfusion mismatching on PetCO 2 , failure to reach an expiratory plateau during rapid respiratory rates, and the technical limitations of PetCO 2 devices to interpret CO 2 in small tidal volume states. 2 5 9-12 Recent technological advances in PetCO 2 monitoring, such as smaller sample volumes and sample cells calibrated to neonatal tidal volumes, have attempted to overcome the limitations. 13 Some authors advocate PetCO 2 as an acceptable method of approximation of PaCO 2 trends in newborn infants. 10 14-16 The Newborn Emergency Transport Service of Victoria (NETS) is the largest neonatal transport service in Australasia. More than 900 infants a year are transported, with approximately one third ventilated. Monitoring of TcPCO 2 and oxygen saturation have been standard practice for five years to indicate ventilation adequacy during transport, and previous unpublished data have shown a close correlation between TcPCO 2 and PaCO 2 .
Arterial blood gases and TcPCO 2 are commonly used to monitor ventilation. The aim of this study was to assess the accuracy and reliability of PetCO 2 monitoring during neonatal transport.
METHODS
Ventilated infants requiring road transport to a level 3 neonatal intensive care unit during March to August 2002 were recruited if the paediatrician involved in the transport was specifically trained to use both PetCO 2 and TcPCO 2 monitors, an arterial catheter was being used, endotracheal tube position could be confirmed by chest radiograph before transport, and both TcPCO 2 and PetCO 2 monitoring could be started before the first arterial blood gas was measured by the NETS team. Because of the effects of barometric pressure on PetCO 2 , infants transported by air were not studied. 5 Informed parental consent was obtained for each infant before transport.
Infants were not studied if they were older than 28 days, had a capillary refill time of greater than two seconds, or TcPCO 2 or PetCO 2 readings could not be made or were lost during transport.
TcPCO 2 was measured using the Microgas 7650 system (weight 5.6 kg) with Combi.M sensor 82 (Linde, Basel, Switzerland) applied to the skin of the anterior chest or abdomen. The manufacturers report that the Combi.M sensor 82, once calibrated, will remain accurate for up to four hours at one site. PetCO 2 was measured using a side stream end tidal analyser specifically designed for neonatal use (the Agilent Microstream system; Agilent Technologies, Andover, Massachusetts, USA); a result was the highest of five consecutive measurements. 13 Arterial blood gases were analysed with the i-STAT portable clinical analyser (i-STAT Corporation, East Windsor, New Jersey, USA). Infants were ventilated using the Hoekloos Infant ventilator Mark 3 The severity of each baby's lung disease was determined by calculating the alveolar to arterial oxygen tension ratio (PAO 2 / PaO 2 ratio) where PAO 2 = (Barometric pressure 2 47) 6 (FIO 2 2 PaO 2 ). Severe lung disease was defined as a PAO 2 / PaO 2 ratio ,0.3. A PAO 2 /PaO 2 ratio of ,0.3 has been associated with less precision of PetCO 2 measurements to estimate PaCO 2 . 15 The parents of all infants enrolled in the study provided written and signed informed consent for their infants to be transported by NETS and this involved specific consent to the use of all devices used in the study. This study was discussed with the Royal Women's Hospital Ethics in Human Research Committee. It was decided that formal ethics approval was not required as the above written informed consent adequately informed the parents and addressed the ethical issues of the study.
Statistical analysis
The differences between PaCO 2 , TcPCO 2 , and PetCO 2 (expressed as P (a-Tc) CO 2 , P (a-Et) CO 2 , and P (Tc-Et) CO 2 respectively) were analysed using a Student's paired t test, and their correlations were calculated. The Bland-Altman technique was used to assess agreement and repeatability. 17 A bias of less than ¡ 0.7 kPa was considered clinically acceptable. Intrasubject P (Tc-Et) CO 2 variability over time was calculated.
RESULTS
Twenty six infants were enrolled, but five were excluded because the PetCO 2 could not be continuously measured in three, both TcPCO 2 and PetCO 2 could not be measured in another, and in the fifth infant the initial blood gas was venous. Table 1 summarises the characteristics of the 21 infants. A total of 21 P (a-Tc) CO 2 and P (a-Et) CO 2 differences and 82 P (Tc-Et) CO 2 differences (median recordings per subject 4.0 (range 2-10)) were calculated.
There was a linear relation between PetCO 2 , PaCO 2 , and TcPCO 2 . However, PetCO 2 underestimated PaCO 2 by an average of 1.04 kPa (table 2, fig 1) . Only 48% of PetCO 2 recordings were within 1.0 kPa of the paired PaCO 2 . The bias of the PetCO 2 values was independent of the PaCO 2 .
TcPCO 2 was closely related to PaCO 2 , with no significant difference between the two measurements (table 2). Two thirds of TcPCO 2 readings were within 0.7 kPa of the PaCO 2 , Average CO 2 v P (a-Et) CO 2 Mean + 2SD Mean of differences Mean -2SD Figure 1 Bland-Altman plot of the difference between PaCO 2 and PetCO 2 (P (a-Et) CO 2 ) against average CO 2 . fig 3) .
There was no significant relation between PetCO 2 accuracy and severity of lung disease ( Most of the infants in this study had mechanical ventilation instigated by the transport team; knowledge of any changes in the CO 2 is essential for safe delivery of ventilation. Frequent PaCO 2 measurements are not practical during neonatal transport; a reliable non-invasive indicator of PaCO 2 is essential. Calibrated TcPCO 2 is an acceptable surrogate for PaCO 2 trends over time. Transcutaneous gas monitoring is an established and validated practice in neonatology. 3 Newborn infants are particularly suited to transcutaneous monitoring because of their thin skin. Although proper use is dependent on appropriate training and placement, the only practical limitations are skin perfusion (which may be altered by vasoconstrictive agents, hypovolaemia, and oedema) and the temperature produced by the device. The response time of TcPCO 2 is too slow (30-50 seconds) to allow monitoring of the respiratory pattern. 19 TcPCO 2 monitoring in neonatal transport has previously been evaluated and shown to result in improved ventilation on arrival at the receiving institution. 1 20 Many authors have reported a good correlation between PetCO 2 , TcPCO 2 , and PaCO 2 in newborn infants, but in only three studies that evaluated PetCO 2 was the relation assessed using the Bland-Altman technique. 14 21 in 25 infants and toddlers (up to 48 months of age) receiving mechanical ventilation for respiratory failure; the P (a-Tc) CO 2 difference in this study was 0.31 (0.18) kPa. Sivan et al 15 obtained a clinically acceptable P (a-Et) CO 2 result, with a mean difference of 0.45 (0.88) kPa in a study involving 134 children (aged 2 days to 16 years) receiving mechanical ventilation. The mean P (a-Tc) CO 2 in this group was 20.17 (0.96) kPa. The P (a-Tc) CO 2 bias was related to skin perfusion but remained clinically acceptable. Primary diagnosis was not described in this study, nor was the proportion of the population who were newborn infants, making inference to the neonatal population difficult. Sivan and colleagues concluded that the degree of the P (a-Et) CO 2 bias was reduced in children with mild lung disease, as defined by a PAO 2 /PaO 2 ratio of .0.3. In the cohort with severe lung disease, the mean P (a-Et) CO 2 1.04 (0.97) kPa was similar to our study.
Parenchymal lung disease with ventilation perfusion (V/Q) mismatching and a PaO 2 /P A O 2 ,0.3 is a feature of most causes of neonatal respiratory failure. During our study, only two infants did not require oxygen, and nearly all had parenchymal lung disease. Our study was not designed to assess the relation between degree of lung disease and PetCO 2 accuracy.
PetCO 2 monitoring has been validated in adult ventilated patients and healthy anaesthetised infants, but the infants in group.bmj.com on September 20, 2017 -Published by http://fn.bmj.com/ Downloaded from our study had respiratory failure. 10 18 PetCO 2 is dependent on alveolar CO 2 (PACO 2 ) and the site of sampling. Non-uniform alveoli CO 2 emptying patterns in patients with large ventilation perfusion mismatching result in PACO 2 underestimating PaCO 2 . 5 22 Technical limitations of end tidal analysis in patients with high rate, low tidal volume breathing would have contributed to the difference between PetCO 2 and PaCO 2 . To account for the fresh inhaled gas admixture during proximal PetCO 2 sampling, a minimum sampling flow rate of 150 ml/min is required. 5 The end tidal analyser used in our study sampled at 50 ml/min. Despite manufacturer assurances, this may have had an impact on our results. The response time of end tidal analysers must be less than the respiratory cycle. The response time of the end tidal analyser used was 190 milliseconds, which is adequate for the ventilation rates used during the study, although at high respiratory rates with a short expiratory time, all exhaled alveolar gas would not have migrated to a proximal end tidal sampling site on completion of each respiratory cycle. 5 The relation between TcPCO 2 and PetCO 2 was not constant over time within individuals, even when both values were adjusted to PaCO 2 . In our opinion PetCO 2 monitoring cannot be used to reliably monitor trends in PaCO 2 over time in newborn infants with lung disease.
Despite our findings, PetCO 2 monitoring may offer some benefits over TcPCO 2 monitoring. Primarily the ability to rapidly and reliably confirm endotracheal tube position within the trachea, with either a capnograph or colorimetric end tidal CO 2 indicator, is of great benefit within the noisy environment of neonatal transport. 7 This study did not aim to assess the ability of PetCO 2 or TcPCO 2 to indicate endotracheal tube position. Inadvertent extubation is not a common occurrence in our transport population and did not occur in any of the neonates involved in this study. Further study is required to determine the role of PetCO 2 in ensuring the endotracheal tube position during transport.
CONCLUSIONS
Owing to the bias of about 21 kPa and lack of consistency in measuring PaCO 2 over time, PetCO 2 cannot be recommended during neonatal transport to monitor ventilation. TcPCO 2 monitoring was generally more precise, reliable, and agreed with PaCO 2 . TcPCO 2 monitoring is the preferred method of non-invasive CO 2 monitoring during neonatal transport. 
